Close Menu

Colorectal Cancer

News and reporting on colorectal cancer.

In launching its Surveyor Scan KRAS mutation detection kit, Transgenomic will take on DxS' KRAS test, which is being globally marketed by Roche.

At a meeting hosted by the Partners HealthCare Center for Personalized Genetic Medicine last month, the events leading up to the re-labeling for colorectal cancer drugs Vectibix and Erbitux sparked discussion among participants about what Amgen and Bristol-Myers Squibb/ImClone knew about the drugs and when.

The Canadian biomarker test developer attributed the revenue increase to a collaborative research agreement; an Asian biomedical consortium; and sales of its ColonSentry biomarker test.

The Berlin-based firm trimmed its loss on higher sales from collaborations, licenses, and partnerships.

Exact Sciences will combine the Invader chemistry with digital PCR technology.

The Berlin-based company is planning to market the test in Germany, Switzerland, and Austria. Epigenomics will partner with distributors Abbott Molecular and Quest Diagnostics to launch the test in other European countries, as well as the US.

OSU Medical Center will enroll patients who agree to join Coriell's personalized medicine project under the guidance of their primary care physician. The partners will study the impact of using genomic information in treating chronic conditions.

Qiagen said that the acquisition, along with the fact that it has more than 15 companion diagnostic collaborations with pharma companies, provides it with a leading position in the personalized healthcare market.

In an interview with Pharmacogenomics Reporter this week, Hakan Sakul provided a snapshot of Pfizer's efforts in personalized medicine, the company's stance on regulatory issues, and its overall focus on "omics"-guided medicine.

The results from the Australian study may have implications for US consumers, since similar to Australia, US law bars health insurers from discriminating based on genetic information, but not companies providing life and disability insurance.

Pages

Nature News reports that genomics is being applied to trace and try to prevent additional COVID-19 waves.

Rady's Children Hospital and San Diego County are teaming up to test pediatric patients and their families for COVID-19 to gauge the spread of the virus locally, according to the San Diego Union-Tribune.

Wildlife managers aim to boost the genetic diversity of Mexican gray wolves by placing captive-born foster pups into packs with similarly aged wild pups, the Mercury News reports.

In Science this week: Genetic Probability tool identifies likely diagnoses in 45 percent of inflammatory arthritis cases, and more.